Indication

Lymphoid blast phase Philadelphia chromosome positive chronic myelocytic leukemia

Lymphoid blast phase Philadelphia chromosome-positive chronic myelocytic leukemia is an aggressive, advanced-stage hematologic malignancy characterized by the acute transformation of chronic myelocytic leukemia. Read more about Lymphoid blast phase Philadelphia chromosome positive chronic myelocytic leukemia

46 drugs 38 manufacturers

Advertisement

Drugs that treat it

Common Lymphoid blast phase Philadelphia chromosome positive chronic myelocytic leukemia therapies.

Showing 19–27 of 46 drugs

DASATINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+4
DR.REDDY'S LAB

IMATINIB MESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+11
AREVA PHARMACEU

IMATINIB MESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+11
GSMS, INC.

DASATINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+4
APOTEX CORP

IMATINIB MESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+11
CHARTWELL RX LL

IMATINIB MESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+11
AHP

IMATINIB MESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+11
AUROBINDO PHARM

DASATINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+4
PRASCO LABS

DASATINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA·+4
BIOCON PHARMA I
Filter & compare in the drug finder →Opens the drug finder with Lymphoid blast phase Philadelphia chromosome positive chronic myelocytic leukemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Lymphoid blast phase Philadelphia chromosome positive chronic myelocytic leukemia.

Lymphoid blast phase Philadelphia chromosome-positive chronic myelocytic leukemia is an aggressive, advanced-stage hematologic malignancy characterized by the acute transformation of chronic myelocytic leukemia.

Pathophysiologically driven by the reciprocal translocation producing the Philadelphia chromosome and BCR::ABL1 fusion oncoprotein, this state arises primarily in the bone marrow and peripheral blood, though extramedullary involvement can also occur.

It is clinically defined by an uncontrolled expansion of immature lymphoid precursor cells, typically manifesting with 20% or more lymphoblasts in the blood or marrow and mimicking acute lymphoblastic leukemia.

This phase leads to profound bone marrow failure characterized by progressive cytopenias, splenomegaly, systemic B-symptoms, and increased vulnerability to severe infection and bleeding.

Personalize your experience

Follow Lymphoid blast phase Philadelphia chromosome positive chronic myelocytic leukemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it